相关实验视频
Updated: Jun 27, 2025

Sodium Taurocholate Induced Severe Acute Pancreatitis in C57BL/6 Mice
Published on: June 28, 2021
在预测的严重急性胰腺炎中,平衡的溶液与正常的盐水相比:一个渐进的子集群随机试验
Lu Ke1,2, Bo Ye1, Mingfeng Huang1
1Department of Critical Care Medicine, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
均衡多电解质溶液 (BMES) 与正常盐水 (NS) 相比,在预测严重急性胰腺炎 (pSAP) 患者中显著降低血清化物水平. 此外,BMES还改善了临床结果,包括减少了全身炎症反应综合征和增加了无器官衰竭天数.
科学领域:
- 关键护理医学 关键护理医学
- 胃肠病学 胃肠病学
- 液体复苏 复苏 液体复苏 复苏
背景情况:
- 同位素晶体化物是初始急性胰腺炎液体治疗的标准.
- 平衡多电解质溶液 (BMES) 与正常盐水 (NS) 的比较好处仍然不清楚.
研究的目的:
- 为了比较BMES与NS对血清化物水平和预测严重急性胰腺炎 (pSAP) 患者的临床结果的影响.
主要方法:
- 一个多中心,分阶,集群随机试验,涉及pSAP患者 (APACHE II评分≥8,CRP>150 mg/L).
- 研究地点在不同时间段从NS转向BMES流体治疗.
- 主要终点:试验日3的血清化物度;次要终点:临床和实验室测量.
主要成果:
- 与NS (n=147) 相比,使用BMES (n=112) 在第3天的平均血清化物水平显著降低 [101.8 vs 105.8 mmol/L].
- BMES组在第7天显示系统性炎症反应综合征减少 (17.0%vs29.3%) 和更多的无器官衰竭日 (3.9vs3.5天).
- 接受BMES治疗的患者在30日经历了更长的活着和离 ICU/医院的时间.
结论:
- 在pSAP患者中使用BMES会导致更多的生理血清化物水平.
- 这种流体策略与显著的临床益处有关,包括减少炎症和改善器官功能恢复.
更多相关视频
07:10Establishment of a Mouse Severe Acute Pancreatitis Model using Retrograde Injection of Sodium Taurocholate into the Biliopancreatic Duct
Published on: April 1, 2022
07:38Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection
Published on: May 10, 2024
相关概念视频
Acute Pancreatitis II: Clinical Manifestations and Management
Chronic Pancreatitis II: Collaborative Care
Assessment:
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include: